These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28402248)

  • 1. Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
    Beigneux AP; Miyashita K; Ploug M; Blom DJ; Ai M; Linton MF; Khovidhunkit W; Dufour R; Garg A; McMahon MA; Pullinger CR; Sandoval NP; Hu X; Allan CM; Larsson M; Machida T; Murakami M; Reue K; Tontonoz P; Goldberg IJ; Moulin P; Charrière S; Fong LG; Nakajima K; Young SG
    N Engl J Med; 2017 Apr; 376(17):1647-1658. PubMed ID: 28402248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.
    Hu X; Dallinga-Thie GM; Hovingh GK; Chang SY; Sandoval NP; Dang TLP; Fukamachi I; Miyashita K; Nakajima K; Murakami M; Fong LG; Ploug M; Young SG; Beigneux AP
    J Clin Lipidol; 2017; 11(4):964-971. PubMed ID: 28666713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPIHBP1 autoantibody syndrome during interferon β1a treatment.
    Eguchi J; Miyashita K; Fukamachi I; Nakajima K; Murakami M; Kawahara Y; Yamashita T; Ohta Y; Abe K; Nakatsuka A; Mino M; Takase S; Okazaki H; Hegele RA; Ploug M; Hu X; Wada J; Young SG; Beigneux AP
    J Clin Lipidol; 2019; 13(1):62-69. PubMed ID: 30514621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chylomicronemia from GPIHBP1 autoantibodies.
    Miyashita K; Lutz J; Hudgins LC; Toib D; Ashraf AP; Song W; Murakami M; Nakajima K; Ploug M; Fong LG; Young SG; Beigneux AP
    J Lipid Res; 2020 Nov; 61(11):1365-1376. PubMed ID: 32948662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent chylomicronemia caused by intermittent GPIHBP1 autoantibodies.
    Ashraf AP; Miyashita K; Nakajima K; Murakami M; Hegele RA; Ploug M; Fong LG; Young SG; Beigneux AP
    J Clin Lipidol; 2020; 14(2):197-200. PubMed ID: 32107180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPIHBP1 and Plasma Triglyceride Metabolism.
    Fong LG; Young SG; Beigneux AP; Bensadoun A; Oberer M; Jiang H; Ploug M
    Trends Endocrinol Metab; 2016 Jul; 27(7):455-469. PubMed ID: 27185325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.
    Beigneux AP; Fong LG; Bensadoun A; Davies BS; Oberer M; Gårdsvoll H; Ploug M; Young SG
    Circ Res; 2015 Feb; 116(4):624-32. PubMed ID: 25387803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.
    Beigneux AP; Franssen R; Bensadoun A; Gin P; Melford K; Peter J; Walzem RL; Weinstein MM; Davies BS; Kuivenhoven JA; Kastelein JJ; Fong LG; Dallinga-Thie GM; Young SG
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):956-62. PubMed ID: 19304573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.
    Plengpanich W; Young SG; Khovidhunkit W; Bensadoun A; Karnman H; Ploug M; Gårdsvoll H; Leung CS; Adeyo O; Larsson M; Muanpetch S; Charoen S; Fong LG; Niramitmahapanya S; Beigneux AP
    J Biol Chem; 2014 Jul; 289(28):19491-9. PubMed ID: 24847059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase.
    Kristensen KK; Midtgaard SR; Mysling S; Kovrov O; Hansen LB; Skar-Gislinge N; Beigneux AP; Kragelund BB; Olivecrona G; Young SG; Jørgensen TJD; Fong LG; Ploug M
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6020-E6029. PubMed ID: 29899144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.
    Young SG; Fong LG; Beigneux AP; Allan CM; He C; Jiang H; Nakajima K; Meiyappan M; Birrane G; Ploug M
    Cell Metab; 2019 Jul; 30(1):51-65. PubMed ID: 31269429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPIHBP1, an endothelial cell transporter for lipoprotein lipase.
    Young SG; Davies BS; Voss CV; Gin P; Weinstein MM; Tontonoz P; Reue K; Bensadoun A; Fong LG; Beigneux AP
    J Lipid Res; 2011 Nov; 52(11):1869-84. PubMed ID: 21844202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protein of capillary endothelial cells, GPIHBP1, is crucial for plasma triglyceride metabolism.
    Young SG; Song W; Yang Y; Birrane G; Jiang H; Beigneux AP; Ploug M; Fong LG
    Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2211136119. PubMed ID: 36037340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1.
    Voss CV; Davies BS; Tat S; Gin P; Fong LG; Pelletier C; Mottler CD; Bensadoun A; Beigneux AP; Young SG
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7980-4. PubMed ID: 21518912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome.
    Nimonkar AV; Weldon S; Godbout K; Panza D; Hanrahan S; Cubbon R; Xu F; Trauger JW; Gao J; Voznesensky A
    J Biol Chem; 2020 Mar; 295(10):2900-2912. PubMed ID: 31645434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia.
    Strøm TB; Tveita AA; Bogsrud MP; Leren TP
    J Clin Lipidol; 2024; 18(1):e80-e89. PubMed ID: 37981531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.
    Adeyo O; Goulbourne CN; Bensadoun A; Beigneux AP; Fong LG; Young SG
    J Intern Med; 2012 Dec; 272(6):528-40. PubMed ID: 23020258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.
    Franssen R; Young SG; Peelman F; Hertecant J; Sierts JA; Schimmel AW; Bensadoun A; Kastelein JJ; Fong LG; Dallinga-Thie GM; Beigneux AP
    Circ Cardiovasc Genet; 2010 Apr; 3(2):169-78. PubMed ID: 20124439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the lipoprotein lipase-GPIHBP1 complex that mediates plasma triglyceride hydrolysis.
    Birrane G; Beigneux AP; Dwyer B; Strack-Logue B; Kristensen KK; Francone OL; Fong LG; Mertens HDT; Pan CQ; Ploug M; Young SG; Meiyappan M
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1723-1732. PubMed ID: 30559189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain.
    Mysling S; Kristensen KK; Larsson M; Beigneux AP; Gårdsvoll H; Fong LG; Bensadouen A; Jørgensen TJ; Young SG; Ploug M
    Elife; 2016 Jan; 5():e12095. PubMed ID: 26725083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.